Innoviva (INVA) Total Debt (2010 - 2026)
Innoviva posted quarterly Total Debt of $258.1 million for Q1 2026, down 42.5% year-on-year from $448.9 million in Q1 2025, and little changed on a QoQ basis from $257.7 million in Q4 2025.
Innoviva (INVA) has 17 years of Total Debt data on file, last reported at $258.1 million in Q1 2026.
- For the quarter ending Q1 2026, Total Debt fell 42.5% year-over-year to $258.1 million; the trailing twelve-month figure through Mar 2026 stood at $258.1 million (down 42.5% YoY), and the FY2025 full-year result was $257.7 million, down 42.51% from the prior year.
- Total Debt for Q1 2026 stood at $258.1 million, roughly flat from $257.7 million in the prior quarter.
- Across five years, Total Debt topped out at $540.4 million in Q4 2022 and bottomed at $96.0 million in Q1 2022.
- The 5-year median for Total Debt is $446.2 million (2023), against an average of $383.3 million.
- The widest annual swing landed in 2022, when Total Debt plunged 75.37%; it then soared 363.4% in 2023.
- A 5-year view of Total Debt shows it stood at $540.4 million in 2022, then decreased by 17.42% to $446.2 million in 2023, then grew by 0.47% to $448.3 million in 2024, then slumped by 42.51% to $257.7 million in 2025, then advanced by 0.14% to $258.1 million in 2026.
- The last three Total Debt figures came in at $258.1 million (Q1 2026), $257.7 million (Q4 2025), and $257.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 258.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 258.10 Mn |
| Dec 31, 2025 | 257.73 Mn |
| Sep 30, 2025 | 257.38 Mn |
| Jun 30, 2025 | 448.92 Mn |
| Mar 31, 2025 | 448.89 Mn |
| Dec 31, 2024 | 448.34 Mn |
| Sep 30, 2024 | 447.82 Mn |
| Jun 30, 2024 | 447.28 Mn |
| Mar 31, 2024 | 446.76 Mn |
| Dec 31, 2023 | 446.23 Mn |
| Sep 30, 2023 | 445.72 Mn |
| Jun 30, 2023 | 445.20 Mn |
| Mar 31, 2023 | 444.69 Mn |
| Dec 31, 2022 | 540.37 Mn |
| Sep 30, 2022 | 539.81 Mn |
| Jun 30, 2022 | 96.07 Mn |
| Mar 31, 2022 | 96.02 Mn |
| Dec 31, 2021 | 394.65 Mn |
| Sep 30, 2021 | 392.30 Mn |
| Jun 30, 2021 | 389.99 Mn |
| Mar 31, 2021 | 387.73 Mn |
| Dec 31, 2020 | 385.52 Mn |
| Sep 30, 2020 | 383.35 Mn |
| Jun 30, 2020 | 381.23 Mn |
| Mar 31, 2020 | 379.15 Mn |
| Dec 31, 2019 | 377.12 Mn |
| Sep 30, 2019 | 388.64 Mn |
| Jun 30, 2019 | 386.68 Mn |
| Mar 31, 2019 | 384.74 Mn |
| Dec 31, 2018 | 382.86 Mn |
| Sep 30, 2018 | 381.00 Mn |
| Jun 30, 2018 | 486.53 Mn |
| Mar 31, 2018 | 484.59 Mn |
| Dec 31, 2017 | 599.36 Mn |
| Sep 30, 2017 | 603.45 Mn |
| Jun 30, 2017 | 416.04 Mn |
| Mar 31, 2017 | 471.30 Mn |
| Dec 31, 2016 | 716.09 Mn |
| Sep 30, 2016 | 481.47 Mn |
| Jun 30, 2016 | 484.15 Mn |
| Mar 31, 2016 | 483.39 Mn |
| Dec 31, 2015 | 482.14 Mn |
| Sep 30, 2015 | 488.98 Mn |
| Jun 30, 2015 | 483.36 Mn |
| Mar 31, 2015 | 476.95 Mn |
| Dec 31, 2014 | 471.58 Mn |
| Sep 30, 2014 | 460.00 Mn |
| Jun 30, 2014 | 450.00 Mn |
| Dec 31, 2013 | 40.00 Mn |
| Mar 31, 2012 | 13,000.00 |
| Dec 31, 2011 | 69,000.00 |
| Sep 30, 2011 | 109,000.00 |
| Jun 30, 2011 | 162,000.00 |
| Dec 31, 2010 | 275,000.00 |